Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Rapid Micro Biosystems (RPID) Cost of Revenue (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Cost of Revenue for 6 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 11.4% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.1 million through Dec 2025, down 8.93% year-over-year, with the annual reading at $12.1 million for FY2025, 8.93% down from the prior year.
  • Cost of Revenue hit $3.3 million in Q4 2025 for Rapid Micro Biosystems, up from $2.9 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $4.1 million in Q4 2022 to a low of $2.3 million in Q1 2021.
  • Historically, Cost of Revenue has averaged $3.3 million across 5 years, with a median of $3.3 million in 2024.
  • Biggest five-year swings in Cost of Revenue: surged 152.59% in 2021 and later fell 23.35% in 2023.
  • Year by year, Cost of Revenue stood at $3.4 million in 2021, then rose by 22.92% to $4.1 million in 2022, then dropped by 23.35% to $3.2 million in 2023, then dropped by 5.66% to $3.0 million in 2024, then rose by 11.4% to $3.3 million in 2025.
  • Business Quant data shows Cost of Revenue for RPID at $3.3 million in Q4 2025, $2.9 million in Q3 2025, and $3.1 million in Q2 2025.